VistaGen Therapeutics EV - Enterprise Value 2011-2026 | VTGN

Annual EV - Enterprise Value VistaGen Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
20.3 M	-36.8 M	4.13 M	-46.6 M	-77.4 M	29.4 M	24.4 M	7.87 M	15.1 M	18.6 M	31.4 M	23.6 M	28.7 M	42.8 M	-139 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
42.8 M	-77.4 M	5.7 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	-28.9 M	$ 3.85	3.24 %	$ 9.26 B	Australia
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	43.3 B	$ 322.18	-3.36 %	$ 42.2 B	USA
Applied Molecular Transport AMTI	7.6 M	-	-	$ 10.1 M	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
AlloVir ALVR	-55.1 M	-	4.14 %	$ 49.1 M	USA
Burford Capital Limited BUR	3.22 B	$ 4.71	-0.53 %	$ 766 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Cabaletta Bio CABA	253 M	$ 3.51	3.09 %	$ 353 M	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	82.6 M	$ 7.72	4.04 %	$ 76.3 M	USA
Allakos ALLK	122 M	-	-	$ 28.6 M	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-1.76 M	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	563 M	-	-	$ 8.42 M	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	58.2 M	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	11 M	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	1.92 B	$ 22.0	1.48 %	$ 1.03 B	USA
CymaBay Therapeutics CBAY	3.36 B	-	-	$ 3.45 B	USA
BioNTech SE BNTX	-4.91 B	$ 101.75	2.29 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	10.3 M	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	647 M	$ 3.07	-3.15 %	$ 5.05 M	Israel
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
Galectin Therapeutics GALT	306 M	$ 2.25	-12.11 %	$ 144 M	USA
ContraFect Corporation CFRX	24.7 M	-	-5.16 %	$ 5.39 M	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	493 M	$ 1.38	-10.97 %	$ 355 M	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Grifols, S.A. GRFS	11.8 B	$ 8.6	-1.04 %	$ 6.83 B	Spain
Aquestive Therapeutics AQST	540 M	$ 4.28	0.94 %	$ 458 M	USA
Arcutis Biotherapeutics ARQT	3.64 B	$ 23.69	-3.64 %	$ 3.01 B	USA
AIkido Pharma AIKI	9.53 M	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	629 M	$ 1.59	6.71 %	$ 423 M	Britain
Aptose Biosciences APTO	36.2 M	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	174 M	-	-	$ 169 M	USA
Immatics N.V. IMTX	503 M	$ 10.8	-1.86 %	$ 679 M	Germany
Caladrius Biosciences CLBS	-6.94 M	-	-16.75 %	$ 25.8 M	USA
AVROBIO AVRO	-35.4 M	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	122 M	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	2.07 B	$ 33.63	-0.72 %	$ 2.23 B	USA